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Pancreatic cancer is the seventh leading cause of cancer-related deaths in developed countries with an average survival 
rate of less than 9%. Up to 80% of the patients with pancreatic cancer are found to be diabetic at the time of diagnosis. 
Leaves of Ravenala madagascariensis Sonn., have been traditionally used in the treatment of diabetes and was scientifically 
proven to be effective as an antidiabetic, hypolipidemic, renoprotective and antioxidant agent. In the present study, the 
antitumor effect of successive ethanolic leaf extract over two human pancreatic cancer cell lines PANC1 and SW1990 was 
evaluated by MTT assay. The shade dried, powdered leaves of R. madagascariensis, was subjected to successive soxhlet 
extraction with n-hexane, ethyl acetate followed by ethanol, concentrated and evaporated to dryness. The extract was 
subjected to preliminary phytochemical screening and was found to possess alkaloids, flavonoids, saponins, glycosides, 
phenols and tannins. The thin layer chromatography and high performance thin layer chromatography of various extracts of 
R. madagascariensis, was established. Based on the free radical scavenging potential, the ethanol extract was selected for
further cytotoxicity studies. The ethanolic extract exhibited excellent cytotoxic effect against PANC1 and SW1990 with an
IC50 value of 12.58 µg/mL and 18.9 µg/mL respectively. Thus the results validate the antitumor potential of R.
madagascariensis, leaf extract against pancreatic cancer and further studies were aimed at the identification of active
components responsible for the activity.
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Introduction 
Being ranked the seventh leading cause of death 
with a 5-year survival rate of 9%, pancreatic cancer is 
projected to be in third place in causing death 
surpassing breast cancer in future1-3. More than 45,750 
pancreatic cancer-related deaths and 56,770 new cases 
have been reported in the United States in 20194. Risk 
factors include smoking, family history, age, sex, 
diabetes mellitus, obesity, high-fat diet, infections due 
to Helicobacter pylori and periodontal diseases5-9. The 
high morbidity and lethality are due to its difficulty in 
diagnosis at early stages and poor prognosis4. 
Stronger cell invasion and metastasis to other tissues 
add on to the dreadful clinical manifestations of 
pancreatic cancer10-12. Pancreatic cancer is causally 
related to diabetes and insulin resistance. The insulin 
signalling cascade in skeletal muscles is impaired at 
multiple steps in pancreatic cancer. Up to 80% of 
patients with pancreatic cancer are found diabetic at 
the time of diagnosis13. Gemcitabine, the standard 
drug prescribed for pancreatic cancer has a poor 
response rate of less than 20%14-16. This inadequate 
response to the current therapeutics, late detection and 
drug resistance demands the need for extensive 
research in natural products.  
Leaves of Ravenala madagascariensis Sonn., have 
been traditionally used in the treatment of diabetes17. 
The plant extract was scientifically proven to be 
effective as an antidiabetic, hypolipidemic, 
renoprotective and antioxidant agent18-21. The 
antioxidant potential of the plant provoked the 
investigation of its use in pancreatic cancer. The 
present study was aimed at exploring the antitumor 
effect of leaves of R. madagascariensis, in human 
pancreatic cell lines PANC1 and SW1990. 
Materials and Methods 
Chemicals, reagents and cell lines 
All the chemicals and reagents were procured from 









grade. PANC1 AND SW1990 cell lines were obtained 
from the National Centre for Cell Sciences, India, 
Pune (NCCS). The cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% Fetal Bovine Serum (FBS), 
penicillin (100 U/mL), and streptomycin (100 µg/mL) 
in a humidified atmosphere of 5% CO2 at 37 
oC. 
 
Collection and authentication of plant material 
Leaves of R. madagascariensis, (Strelitziaceae) 
were collected from Neyveli, Tamil Nadu during 
December 2018. Fully grown leaves were collected in 
fine dry weather and were stacked loosely in a vertical 
position in a shed for 3 weeks. The plant was 
identified and authenticated (No. PARC/2019/3958) 
by Plant Anatomy Research Centre, Chennai. The 
shade dried leaves were coarsely powdered and used 
for further studies. A voucher specimen has been 
deposited in the Department of Pharmacognosy, SRM 
College of Pharmacy, Kattankulathur, Tamil Nadu, 
India. 
 
Extraction of plant material 
Successive extraction was performed by 
Soxhelation of shade dried and coarsely powdered 
leaves of R. madagascariensis, with n-Hexane, Ethyl 
acetate, and ethanol. The successive extracts were 
then concentrated by using a rotary evaporator at  
40 ºC and the dried extracts were weighed and stored 
at -4 ºC. The percentage yield was calculated using 
the formula,  
 
Percentage yield = X100 
 
Where W2 is the weight of the extract and the 
container, W1 the weight of the container alone and 
W0 the weight of the powdered plant material 
subjected to extraction. Preliminary phytochemical 
screening was carried out to identify the presence of 
various phytochemical constituents in all the three 
successive extracts22. 
 
Thin layer chromatography (TLC) profiling 
TLC was carried out using silica gel G (Merck) 
precoated readymade aluminium TLC plates. The 
extract to be analysed was diluted with the respective 
solvent and then spotted using a capillary tube. 
Various mobile phases were used for development 
and visualised under a UV lamp. Further, the 
developed plates were detected using various 
detecting agents like Dragendorff’s, ninhydrin, 
Libermann-Burchard, conc. sulphuric acid and ferric 
chloride reagents22. 
High performance thin layer chromatography (HPTLC) 
profiling 
HPTLC analysis was carried out with the best 
solvent system obtained from thin layer 
chromatography to detect the maximum number of 
components and peak abundance qualitatively and 
quantitatively. The extracts were dissolved in the 
respective solvents and 10 μL of the sample was 
applied on precoated Silica gel G (Merck) plates 
using Camag Linomat V applicator. The n-hexane and 
ethyl acetate extracts were eluted with Ethylacetate:n-
hexane (6:4) while the ethanolic extract using 
methanol:ethyl acetate (1:1) and scanned under UV at 
254nm/365nm. The data obtained were integrated 
through CAMAG software and the chromatographic 
fingerprints were developed for various extracts22. 
 
Selection of active extract 
Radical scavenging activity by 1, 1,-Diphenyl-2-picrylhydrazyl 
assay (DPPH Assay) 
The n-hexane, ethyl acetate and ethanolic extracts 
of R. madagascariensis, at different concentrations 
(50, 100, 150, 200, 250 μg/mL) were used for the 
study. Ascorbic acid (Sisco Research Laboratories Pvt 
Ltd) was used as the standard control. About 5 mL of 
crude extract or ascorbic acid was mixed with 3 mL 
of 0.004% DPPH solution and kept in dark for 30 
minutes. Absorbance was measured against a blank at 
517 nm using UV-Visible spectrophotometer 
(Shimadzu, Japan). Methanol with DPPH was used as 
a control. All the samples were tested in triplicate and 
the percentage radical scavenging activity was 
calculated using the formula, 
 Percentage	Radical	scavenging	Activity=A-BA ×100  
 
Where A = absorbance of the control (DPPH 
without the sample); B = absorbance of DPPH with 
the sample. The values were presented as Mean±SD 
of three replicates. Bar graphs were plotted with 
percentage scavenging activity against concentration 
and the IC50 values were calculated graphically using 
linear regression23, 24. 
 
Cell viability assay 
Cytotoxicity screening on pancreatic cell lines was 
carried out using 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl--tetrazolium bromide (MTT) assay. The 
basic principle involved is the ability of the 
metabolically active cells to convert yellow 
tetrazolium salt MTT to purple formazan crystals. 
Since the reduction occurs only in metabolically 
active cells, the extent of reduction is a measure of 




cell viability. Cells (1×105/100 μL) were seeded in 
96-well flat bottomed plates and incubated with 
various concentration of successive ethanolic leaf 
extract of R. madagascariensis for 48 hours. After the 
exposure period, the sample was removed and washed 
with phosphate-buffered saline (pH 7.4). Then  
100 µL/well (5 mg/mL) of 0.5% 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-tetrazolium bromide (MTT), 
was added to each well and incubated for 4 hours at 
37 °C. The formazan crystals were then solubilised by 
adding 100 µL of DMSO. The absorbance at 570 nm 
was measured with UV-Spectrophotometer using 
DMSO as a control blank. Percentage cell viability 
was calculated using the formula,  
 Percentage	cell	viability=	 Absorbance	of	treated	cells	at	570nmAbsorbance	of	control	cells	at	570nm 	×100  
 
Bar graphs were plotted using the percentage cell 
viability at Y-axis and concentration of the sample in 
X-axis and the concentration required for a 50% 




All data were presented as the mean±standard 
deviations (SD). The experiment was repeated at least 
in triplicates. Student’s t-test was included to compare 
the difference between groups using Microsoft Excel 




The percentage yield after successive soxhlet 
extraction of the powdered leaves of R.  
madagascariensis, with n-hexane, ethyl acetate and 
ethanol was found to be 2.05, 3.55 and 9.79% w/w, 
respectively. Qualitative preliminary phytochemical 
analysis was performed initially with respective 
chemical reagents to detect the presence of 
phytoconstituents in the powder as well as various 
extracts. The n-hexane extract showed the presence of 
terpenoids, lipids and steroids whereas ethyl acetate 
extract showed positive results indicating the presence 
of alkaloids, phenols and steroids. Ethanol extract 
showed the presence of carbohydrates, flavonoids, 
saponins, alkaloids, tannins and glycosides. (Table 1). 
 
TLC Profiling 
Qualitative chromatographic analysis using TLC 
was performed to separate and identify the single or 
mixture of constituents in each extract. The 
development was carried out with various solvent 
systems at different ratios by trial and error method 
and the Rf values were tabulated in Table 2. Three 
spots were found to be active in n-hexane extract 
(0.62, 0.66, 0.86) whereas ethyl acetate exhibited four 
spots of Rf values 0.67, 0.73, 0.77, 0.79 in the solvent 
system chloroform:methanol (9:1). The ethanol 
extract showed two spots with Rf value 0.56 and 0.92 




HPTLC analysis was performed to detect the 
number of components and the peak abundance 
qualitatively and quantitatively at a higher resolution. 
(Fig. 1, 2) Ethyl acetate extract showed the maximum 
of 7 components in the solvent system Ethyl 
acetate:n-hexane (6:4) and the Rf values at 0.05, 0.09, 
0.26, 0.36, 0.53, 0.60, 0.72. The n-hexane extract 
showed 4 components in the same solvent system 
with Rf values 0.05, 0.39, 0.51, 0.58 and percentage 
abundance peak area of 26.04, 19.12, 23.07 and 
31.77. The ethanol extract in the mobile phase, 
Table 1 — The percentage yield and phytoconstituents of successive extracts of leaves of Ravenala madagascariensis Sonn., 
Solvent used Physical nature Colour Yield (%w/w) Phytoconstituents 




















Flavanoids, glycosides, alkaloids, phenols, tannins, proteins, saponins 
 
 
Table 2 — TLC profile of successive extracts of leaves of Ravenala madagascariensis Sonn. 
Extract  
 
Solvent system No. of spots  UV detection & Rf values 
Near UV 254nm Far UV 365nm 
n-Hexane extract  Chloroform:methanol (9:1) 3 No UV active compounds 0.62, 0.66, 0.86 
Ethyl acetate extract Chloroform:methanol (9:1) 4 No UV active compounds 0.67, 0.73, 0.77, 0.79 
Ethanol extract n- butanol:acetic acid:water (4:1:1) 2 No UV active compounds 0.56, 0.92 




methanol and ethyl acetate (1:1) showed 3 
components with highest percentage abundance peak 
area of 64.83% at Rf value 0.69. 
 
Radical scavenging activity by DPPH assay  
The radical scavenging activity of successive 
extracts of R. madagascariensis at different 
concentration is shown in Fig. 3. All three extracts 
displayed dose-dependent scavenging of radicals. The 
scavenging effect of these extracts with IC50 values 
were in the order – ethanolic extract (52.21 μg/mL) > 
ethyl acetate extract (146.70 μg/mL) > n-hexane 
extract (254.83 μg/mL). The highest scavenging 
potential was exhibited by ethanolic extract compared 
to the standard Ascorbic acid which exhibited the 
highest antioxidant potential with the lowest IC50 
value of 21.73 μg/mL and thereby was selected for the 
further cytotoxic studies. 
 
Cell viability assay 
The cell viability of PANC1 and SW1990 cell lines 
were evaluated by treating increasing concentrations 
of R. madagascariensis, extract at doses ranging from 
0 to 250 µg/mL using MTT assay. The data on the 
percentage cell viability obtained after the exposure of 
cells to various concentrations of the ethanolic extract 
is given in Fig. 4 and 5. A dose-dependent decline in 
cell viability was observed in both the cell lines. The 
IC50 values were found to be 12.58 and 18.9 µg/mL in 
PANC1 AND SW1990 cells, respectively showing a 
higher cytotoxic effect in PANC1 adenocarcinoma 
cell lines compared to SW1990. 
 
 
Fig. 2 — High Performance Thin Layer chromatography of 
successive extracts of leaves of Ravenala madagascariensis Sonn. 




Fig. 3 — Radical scavenging activity of successive extracts of leaves 
of Ravenala madagascariensis Sonn., by DPPH assay. Plot of 
percentage radical scavenging activity against various concentrations 
of successive extracts. Data are expressed as mean+SD of triplicates. 
The IC50 value was found to be 254.83 µg/mL, 146.70 µg/mL, 52.20 
µg/mL and 21.73 µg/mL for n-Hexane extract, Ethyl acetate extract, 
ethanol extract and Ascorbic acid repectively. 
 
Fig. 1 — High Performance Thin Layer chromatography of
successive extracts of leaves of Ravenala madagascariensis Sonn.
under normal and UV (365nm) lamp (A- n-hexane extract,
B-Ethylacetate extract, C-Ethanol extract) 






Fig. 4 — Effect of leaves of Ravenala madagascariensis Sonn., 
on PANC1 cell line using cell viability assay. Plot of percentage 
cell viability against various concentrations of successive 
ethanolic leaf extract for 48 h in PANC1 cells. 0.5% DMSO was 
used as control. Data are expressed as mean+SD of triplicates. 




Fig. 5 — Effect of leaves of Ravenala madagascariensis Sonn., 
on SW1990 cell line using cell viability assay. Plot of percentage 
cell viability against various concentrations of successive 
ethanolic leaf extract for 48 h on SW1990 cells. 0.5% DMSO was 
used as control. Data are expressed as mean+SD of triplicates. 
The IC50 value was found to be 18.9 µg/mL. 
 
Discussion 
Allopathic medicine targets specific malignant 
molecular mechanisms whereas alternative medicine 
follows a holistic approach in treating the entire 
human body28. Insufficient preclinical and clinical 
data regarding the safety and efficacy of plant extracts 
remain a major drawback which in turn further 
demands serious investigations in this area of 
research. Several studies suggest that Type II diabetes 
occurs as a disease manifestation and a major 
prognostic factor for pancreatic cancer13. Molecular 
and genetic studies comparing diabetic patients at 
different stages exhibit molecular overlaps suggesting 
the relationship between pancreatic cancer and 
diabetes29. 
R. madagascariensis has been reported to be 
effective against diabetes and its associated 
disorders18-20. Its promising antioxidant potential and 
the presence of flavonoids led to further research on 
its anticancer activity21. In the present study, various 
extracts of leaves of R. madagascariensis, were 
prepared by successive soxhlet extraction using n-
hexane, ethyl acetate and ethanol to extract the 
phytoconstituents according to their increasing 
polarity. The ethanolic extract showed the highest 
percentage yield of 9.79% w/w followed by ethyl 
acetate (3.55% w/w) and n-hexane (2.05% w/w). 
The TLC and HPTLC profiling of all the 
successive extracts (Table 2 and Fig. 1, 2) provide a 
promising note on the presence and number of 
phytoconstituents. The Rf value of each 
phytoconstituent differs with different solvent 
systems. The selection of the solvent system for a 
particular extract can be achieved only by analysing 
the Rf values of compounds in different solvent 
systems30. The chromatographic profile of successive 
extracts provides valuable information on the nature, 
polarity and separation of compounds from the plant 
extract. 
Excessive production of free radicals emerging 
beyond the control of a natural antioxidant defense 
system of the body results in oxidative stress-related 
disorders including cancer, ageing, cardiovascular and 
neurodegenerative diseases. The DPPH radical 
scavenging assay is one of the widely used assays 
which involves DPPH, a stable free radical with the 
absorbance maximum at 517 nm. DPPH becomes 
stable upon acceptance of an electron or hydrogen 
atom. The extract with antioxidant activity should 
possess hydrogen donating capacity which can 
convert the DPPH free radical into nonradical 
diphenyl picryl hydrazine turning purple to 
yellow24,31,32. The various successive extracts the 
leaves of R. madagascariensis, were screened for 
radical scavenging potential by DPPH assay. Among 
the successive extracts, the ethanolic extract was 
found to display stronger scavenging efficacy than the 
ethyl acetate and n-hexane extract as indicated by 
their IC50 values. The lower the IC50 value, the 
stronger is the scavenging activity as exhibited by the 
standard natural antioxidant Ascorbic acid. 
Based on the radical scavenging potential the 
ethanolic extract of leaves of R. madagascariensis, 
was selected for its antiproliferative activity against 
pancreatic cancer. For the in-vitro cytotoxic studies 
two pancreatic cell lines PANC-1 and SW1990 were 
used. PANC-1 human pancreatic adenocarcinoma cell 




line was selected based on their expression of 
multidrug resistance protein and poor sensitivity to 
Gemcitabine, the widely prescribed drug against 
pancreatic cancer33-36. Park et al., has reported 
Gemcitabine with an IC50 value of 10 nM in PANC-1 
cell lines37. This report was also compared by Pak et al., 
which involved a combinational therapy of a herbal 
mixture extract (H3) exhibiting an IC50 value of 0.05 
mg/mL along with Gemcitabine (3 nM) showing a 
better cytotoxic activity than H3 the extract alone 
(0.07 mg/mL)38. In another study carried out by Yue 
et al., Gemcitabine was reported with an IC50 value 
of 0.079 μg/mL in SW1990 cell line39. In the  
present investigation, it was found that the cytotoxic 
effect of ethanolic extract of R. madagascariensis, on 
PANC-1 and SW1990 was remarkable and with 
almost close IC50 values of 12.58 and 18.9 μg/mL. 
The study is in accordance with the American Cancer 
Institute which states a drug to be a promising 
candidate if the EC50 value of a crude extract is less 
than 30 μg/mL40,41. Thus the study validates the  
in-vitro antitumor activity of the successive ethanolic 
leaf extract against two human pancreatic cell lines 
PANC1 and SW1990 which can be attributed to the 
presence of flavonoid enriched phytoconstituents. 
 
Conclusion 
In the present work, the phytochemical, radical 
scavenging and cytotoxic activity of successive 
extracts of leaves of R. madagascariensis were 
screened. Preliminary phytochemical screening 
revealed the presence of various phytoconstituents 
including terpenoids, lipids, steroids, alkaloids, 
flavonoids, saponins, tannins and glycosides. TLC 
and HPTLC were carried out. All the three successive 
extracts, the n-hexane, the ethyl acetate and ethanolic 
leaf extracts were subjected to free radical scavenging 
activity. The ethanolic extract was found to possess 
the highest antioxidant activity with IC50 value of 
52.21 μg/mL. Hence, the ethanolic extract was 
selected for the further in-vitro anti-cancer cell  
line studies. The ethanolic extract of leaves of  
R. madagascariensis showed promising cytotoxic 
activity in PANC-1 and SW1990 cell lines with an 
IC50 value of 12.58 and 18.9 µg/mL, respectively 
against pancreatic cancer. The study strongly suggests 
the ethanolic extract can turn out to be an effective 
flavonoid-rich extract against oxidative damage and 
pancreatic cancer. Thus, the current work provides 
valuable data for further studies that can be aimed at 
exploring the phytoconstituents responsible for the 
biological activity and the biochemical mechanisms 
involved in it. 
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